Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis

NCT02049294 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Steroid and/or Prednisone Dependent Asthma
Eosinophilic Bronchitis

Interventions

BIOLOGICAL: Omalizumab (Xolair)
DRUG: Placebo

Sponsor

McMaster University

Collaborators

[object Object]